Our mutual fiends: cancer research in a time of COVID-19

我们共同的敌人:新冠疫情时期的癌症研究

阅读:1

Abstract

The impact of the COVID-19 pandemic on health services in the UK and around the world cannot be understated. Cancer care services, patient and cancer research communities have been particularly affected. Screening services, treatment and clinical trials have been halted. Research laboratories have been closed or repurposed to tackle the pandemic. Despite these profound setbacks, there are ways in which the pandemic is accelerating areas of cancer research. In the context of a new cancer research exhibition planned by the Science Museum Group, Cancer Revolution: Science, innovation and hope, this essay draws out some remarkable parallels between cancer science and the remarkable research effort seeking to tackle the COVID-19 pandemic. Knowledge and therapeutic approaches from seemingly unrelated fields of medical research are opening up new possibilities to control both diseases. As the race to control COVID-19 has shown, the more research angles, disciplines and tools and people we can bring together to tackle the challenge cancer poses, the better our chances of staying ahead of this disease for more of us now and in future.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。